Early Prediction of Radiotherapeutic Efficacy in a Mouse Model of Non-Small Cell Lung Carcinoma Using 18F-FLT and 18F-FDG PET/CT-Reference-Cited by-同舟云学术

Early Prediction of Radiotherapeutic Efficacy in a Mouse Model of Non-Small Cell Lung Carcinoma Using 18F-FLT and 18F-FDG PET/CT

Published:2023 Issue:3.4 Volume:70 Page:361-368
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Otani Tamaki¹,Ikushima Hitoshi²,Bando Yoshimi³,Yamashita Michiko⁴,Kuwahara Kenmei⁵,Otsuka Hideki⁶,Kondo Kazuya⁷,Miyoshi Hirokazu¹

Affiliation:

1. Advance Radiation Research, Education, and Management Center, Tokushima University, Tokushima, Japan

2. Department of Therapeutic Radiology, Institute of Biomedical Science, Tokushima University, Tokushima, Japan

3. Department of Pathology and Laboratory Medicine, Institute of Biomedical Science, Tokushima University, Tokushima, Japan

4. Department of Analytical Pathology, Institute of Biomedical Science, Tokushima University, Tokushima, Japan

5. Faculty of Health Science, Tokushima University Graduate School of Medicine, Tokushima University, Tokushima, Japan

6. Department of Medical Imaging/Nuclear Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

7. Department of Oncological Medical Services, Institute of Biomedical Science, Tokushima University, Tokushima, Japan

Publisher

University of Tokushima Faculty of Medicine

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/70/3.4/70_361/_pdf

Reference25 articles.

1. 1. Thomas M, Macha HN, Ukena D, Hamm M, Deppermann M, Semik M, Riesenbeck D, R?be C, Heinecke A:Cisplatin/etoposide (PE) followed by twice-daily chemoradiation (hfRT/CT) versus PE alone before surgery in stage III non-small cell lung cancer (NSCLC):a randomised phase III trial of the German Lung Cancer Cooperative Group (GLCCG). J Clin Oncol ?22:7004, 2004

2. 2. Faber LP, Kittle CF, Warren WH, Bonomi PD, Taylor 4th SG, Reddy S, Lee MS:Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg 47:669-75;discussion 676-7, 1989

3. 3. Skarin A, Jochelson M, Sheldon T, Malcolm A, Oliynyk P, Overholt R, Hunt M, Frei 3rd E:Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer:Long-term follow-up in 41 patients. J Surg Oncol 40:266-74, 1989

4. 4. Okawara G, Mackay JA, Evans WK, Ung YC:Management of unresected stage III non-small cell lung cancer:a systematic review. J Thorac Oncol 1:377-93, 2006

5. 5. Albain KS, Scott CB, Rusch VR, Turrisi AT, Shepherd FA, Smith C, Gandara DR, Johnson DH, Green MR, Miller RC, for RTOG, SWOG, NCIC-CTG, ECOG, CALGB:NCCTG Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer:initial results from intergroup trial 0139 (RTOG 93-09). Proc Am Soc Clin Oncol 22:621, 2003